Diamond Biofund Income Statement

Financials in millions TWD. Fiscal year is January - December.

Millions TWD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Other Revenue	-1,073	-2,229	-2,440	1,016	3,064
Revenue	-1,073	-2,229	-2,440	1,016	3,064
Revenue Growth (YoY)	-	-	-	-66.85%	-52.88%
Gross Profit	-1,073	-2,229	-2,440	1,016	3,064
Selling, General & Admin	119.94	152.27	148.18	101.92	64.27
Amortization of Goodwill & Intangibles	0.54	0.41	0.51	0.31	0.11
Operating Expenses	147.92	180.85	158.03	113.39	76.13
Operating Income	-1,221	-2,410	-2,598	902.24	2,988
Interest Expense	-3.09	-3.77	-0.81	-0.25	-0.55
Interest & Investment Income	53.09	15.15	16.24	0.86	0.12
Other Non Operating Income (Expenses)	-2.64	1.85	-1.7	-21.74	-26.56
Pretax Income	-1,174	-2,396	-2,584	881.12	2,961
Income Tax Expense	0.92	121.63	-0.41	83.34	108.98
Net Income	-1,175	-2,518	-2,583	797.78	2,852
Net Income to Common	-1,175	-2,518	-2,583	797.78	2,852
Net Income Growth	-	-	-	-72.02%	-53.17%
Shares Outstanding (Basic)	852	850	779	749	804
Shares Outstanding (Diluted)	852	850	779	770	809
Shares Change (YoY)	0.18%	9.19%	1.21%	-4.90%	18.16%
EPS (Basic)	-1.38	-2.96	-3.32	1.06	3.55
EPS (Diluted)	-1.38	-2.96	-3.32	1.04	3.52
EPS Growth	-	-	-	-70.45%	-60.43%
Free Cash Flow	-264.25	1,125	-2,587	471.63	-300.42
Free Cash Flow Per Share	-0.31	1.32	-3.32	0.61	-0.37
Dividend Per Share	-	-	-	0.170	0.200
Dividend Growth	-	-	-	-15.33%	-
Gross Margin	-	-	-	100.00%	100.00%
Operating Margin	-	-	-	88.84%	97.52%
Profit Margin	-	-	-	78.55%	93.08%
Free Cash Flow Margin	-	-	-	46.44%	-9.81%
EBITDA	-1,214	-2,404	-2,597	903.57	2,990
EBITDA Margin	-	-	-	88.97%	97.59%
D&A For EBITDA	7.41	5.95	1	1.33	2.31
EBIT	-1,221	-2,410	-2,598	902.24	2,988
EBIT Margin	-	-	-	88.84%	97.52%
Effective Tax Rate	-	-	-	9.46%	3.68%

Updated Dec 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.